StockData

Black Hawk Acquisition Corp (BKHA) stock

BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 4/30
$6.48−2.13 (-24.74%)

Close on Nov 19, 2026Market cap $26.92MP/E –Yield –

Black Hawk Acquisition net income

Net income is the profit left for shareholders after every expense, interest and tax.

Black Hawk Acquisition's net income for the twelve months ending Aug 31, 2026 was $1.30M, down 37.7% year over year. For fiscal 2025 it was $1.33M, down 30.6% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2025Nov 30, 2025$1.33M-30.6%
FY2024Nov 30, 2024$1.92M–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Aug 31, 2026$1.07M+596.1%
Q2 FY2026CQ2 2026May 31, 2026$88.93K-82.9%
Q1 FY2026CQ1 2026Feb 28, 2026$139.81K-78.8%
Q4 FY2025CQ4 2025Nov 30, 2025-$3.77K-100.5%
Q3 FY2025CQ3 2025Aug 31, 2025$154.40K-82.5%
Q2 FY2025CQ2 2025May 31, 2025$520.54K+67.4%
Q1 FY2025CQ1 2025Feb 28, 2025$658.38K–
Q4 FY2024CQ4 2024Nov 30, 2024$751.70K–
Q3 FY2024CQ3 2024Aug 31, 2024$883.77K–
Q2 FY2024CQ2 2024May 31, 2024$310.94K–
Q1 FY2024CQ1 2024Feb 29, 2024-$30.70K–

More Black Hawk Acquisition figures

See a number that looks wrong?